Xu–Ting Zhi
Shandong University(CN)
Publications by Year
Research Areas
Hepatocellular Carcinoma Treatment and Prognosis, Cancer, Hypoxia, and Metabolism, Cholangiocarcinoma and Gallbladder Cancer Studies, Liver Disease Diagnosis and Treatment, Eicosanoids and Hypertension Pharmacology
Most-Cited Works
- → Long Non-Coding RNA (LncRNA) Urothelial Carcinoma Associated 1 (UCA1) Increases Multi-Drug Resistance of Gastric Cancer via Downregulating miR-27b(2016)113 cited
- → COX-2/PGE2 Axis Regulates HIF2α Activity to Promote Hepatocellular Carcinoma Hypoxic Response and Reduce the Sensitivity of Sorafenib Treatment(2018)110 cited
- → Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition)(2022)106 cited
- → TMPRSS4 Drives Angiogenesis in Hepatocellular Carcinoma by Promoting HB‐EGF Expression and Proteolytic Cleavage(2019)86 cited
- → Doxorubicin-loaded mesoporous magnetic nanoparticles to induce apoptosis in breast cancer cells(2014)51 cited
- → Mannose‐mediated inhibitory effects of PA‐MSHA on invasion and metastasis of hepatocellular carcinoma via EGFR/Akt/IκBβ/NF‐κB pathway(2014)48 cited
- → Preoperative Albumin-Bilirubin Score for Postoperative Solitary Hepatocellular Carcinoma within the Milan Criteria and Child-Pugh A Cirrhosis(2017)48 cited
- → A Comparison of Hepatic Mucinous Cystic Neoplasms With Biliary Intraductal Papillary Neoplasms(2009)47 cited
- → TMPRSS4 facilitates epithelial-mesenchymal transition of hepatocellular carcinoma and is a predictive marker for poor prognosis of patients after curative resection(2015)46 cited
- → Intramuscular delivery of antiangiogenic genes suppresses secondary metastases after removal of primary tumors(2004)28 cited